Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine

3 Jun 2022

Abstract excerpt

Lung adenocarcinoma (LUAD) is one of the most common histological subtypes of lung cancer. The aim of this study was to construct consensus clusters based on multi-omics data and multiple algorithms. In order to identify specific molecular characteristics and facilitate the use of precision medicine on patients we used gene expression, DNA methylation, gene mutations, copy number variation data, and clinical data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35721082
DOI: 10.3389/fmed.2022.894338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise MedicinePMID 35721082Read ↗

Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity Read ↗

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung AdenocarcinomaSemantic proximity Read ↗

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response predictionSemantic proximity Read ↗

Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsSemantic proximity Read ↗

Comprehensive multi-omics integration uncovers mitochondrial gene signatures for prognosis and personalized therapy in lung adenocarcinoma.Semantic proximity Read ↗

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity Read ↗

Machine Learning Based Combination of Multi-omics Data for Subgroup Identification in Non-small Cell Lung CancerSemantic proximity Read ↗

High-resolution lung adenocarcinoma expression subtypes identify tumors with dependencies on <i>MET, CDK4, CDK6</i> , and <i>PD-L1</i>Semantic proximity Read ↗

Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsSemantic proximity Read ↗

Integrated Multi-Omics Analysis of Lung Adenocarcinoma (TCGA-LUAD): A Comprehensive Study of Genomic, Epigenomic, Copy Number Variations, and Transcriptomic AlterationsSemantic proximity Read ↗

High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities.Semantic proximity Read ↗

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUADSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.